We Should All Be Science Critics
By John Horgan,
Scientific American
| 08. 05. 2019
A while back my school, Stevens Institute of Technology, created a new major called science and technology studies, or STS. It seemed a little amorphous, but I felt an affinity for it. Also, I’ve liked pretty much every STS scholar I’ve met. They are a diverse bunch, both in personality and interests, but they all grapple with compelling issues, ranging from allergies and pharmaceuticals to marine biology and nuclear weapons (and that's just at Stevens). One of the most impressive STS scholars I've met is a pioneer of the field, Sheila Jasanoff. Born and raised in India (Jasanoff is her husband’s name), she ended up at Harvard, where she earned a bachelor’s in mathematics, law degree and doctorate in linguistics. After founding an STS program at Cornell, she returned to Harvard to create its STS program, which she oversees. Jasanoff is an imposing woman, a force of nature wrapped in a sari. She has thought especially hard--and written many articles and books--about the role of science and technology in a democracy. The time seems right to ask her a few questions. – John Horgan...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...